Stability of the Gross Motor Function Classification System over time in children with cerebral palsy.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
12 2022
Historique:
revised: 06 07 2022
received: 21 07 2021
accepted: 13 07 2022
pubmed: 9 8 2022
medline: 3 11 2022
entrez: 8 8 2022
Statut: ppublish

Résumé

To assess the stability of the Gross Motor Functional Classification System (GMFCS) in children with cerebral palsy (CP) from time of preliminary diagnosis (~2 years of age) to time of diagnosis (~5 years of age), and to examine factors associated with reclassification. We conducted a longitudinal study using a sample from the Canadian CP Registry. Stability was analysed by using the percentage of agreement between timepoints and a weighted prevalence and bias adjusted kappa statistic. Univariate and multivariate logistic regressions were performed to identify variables associated with reclassification. The study included 1670 children (857 males, 713 females) with a mean age of 11 years 4 months (SD 4 years, range 3 years 5 months-20 years 1 month) at time of data extraction (3rd September 2019), of which 1435 (85.9%) maintained a stable GMFCS, with a weighted kappa of 0.91 (95% confidence interval 0.89-0.92). Univariate logistic regression showed that initial GMFCS level, CP subtype, and the presence of cognitive impairment were associated with the likelihood of change in the GMFCS level (p < 0.1). In the multivariate analysis, however, the likelihood was associated with initial GMFCS level only (odds ratio 7.10-8.88, p < 0.00). The GMFCS has good stability in early childhood. For the majority of children, it is predictive of their long-term motor function. The Gross Motor Function Classification System (GMFCS) rating in early childhood is stable over time. There is no directionality in the reclassification of the GMFCS. The initial GMFCS level was related to the likelihood of change in follow-up GMFCS level.

Identifiants

pubmed: 35941090
doi: 10.1111/dmcn.15375
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1487-1493

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 Mac Keith Press.

Références

Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007; 109: 8-14.
Paulson A, Vargus-Adams J. Overview of four functional classification systems commonly used in cerebral palsy. Children (Basel) 2017; 4: 30.
Bodkin AW, Robinson C, Perales FP. Reliability and validity of the gross motor function classification system for cerebral palsy. Pediatr Phys Ther 2003; 15: 247-52.
Chen A, Dyck Holzinger S, Oskoui M, Shevell M, Canadian Cerebral Palsy R. Losing a diagnosis of cerebral palsy: a comparison of variables at 2 and 5 years. Dev Med Child Neurol 2020; 62: 83-8.
Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-23.
Gorter JW, Ketelaar M, Rosenbaum P, Helders PJ, Palisano R. Use of the GMFCS in infants with CP: the need for reclassification at age 2 years or older. Dev Med Child Neurol 2009; 51: 46-52.
Park E-Y. Stability of the gross motor function classification system in children with cerebral palsy for two years. BMC Neurol 2020; 20: 172.
Wood E, Rosenbaum P. The gross motor function classification system for cerebral palsy: a study of reliability and stability over time. Dev Med Child Neurol 2000; 42: 292-6.
Palisano RJ, Cameron D, Rosenbaum PL, Walter SD, Russell D. Stability of the gross motor function classification system. Dev Med Child Neurol 2006; 48: 424-8.
Palisano RJ, Avery L, Gorter JW, Galuppi B, McCoy SW. Stability of the Gross Motor Function Classification System, Manual Ability Classification System, and Communication Function Classification System. Dev Med Child Neurol 2018; 60: 1026-32.
Shevell MI, Dagenais L, Hall N, Consortium R. Comorbidities in cerebral palsy and their relationship to neurologic subtype and GMFCS level. Neurology 2009; 72: 2090-6.
Shevell M, Dagenais L, Oskoui M. The epidemiology of cerebral palsy: new perspectives from a Canadian registry. Semin Pediatr Neurol 2013; 20: 60-4.
Shevell MI, Dagenais L, Hall N, Consortium R. The relationship of cerebral palsy subtype and functional motor impairment: a population-based study. Dev Med Child Neurol 2009; 51: 872-7.
Oskoui M, Ng P, Zaman M, Buckley D, Kirton A, van Rensburg E, Wood E, Shevell M, Majnemer A. Complementary and Alternative Therapy Use in Children with Cerebral Palsy. Can J Neurol Sci 2021; 48: 408-14.
Kramer MS, Platt RW, Wen SW, Joseph K, Allen A, Abrahamowicz M, Blondel B, Bréart G, System FIHSGotCPS. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108: e35-e.
Barbier A, Boivin A, Yoon W, Vallerand D, Platt RW, Audibert F, Barrington KJ, Shah PS, Nuyt AM, Network CN. New reference curves for head circumference at birth, by gestational age. Pediatrics 2013; 131: e1158-e67.
Bax MC. Terminology and classification of cerebral palsy. Dev Med Child Neurol 1964; 6: 295-7.
Mac Keith R, MacKenzie I, Polani P. The Little Club: Memorandum on Terminology and Classification of ‘Cerebral Palsy’. Dev Med Child Neurol 1959; 1: 27-35.
Minear W. A classification of cerebral palsy. Pediatrics 1956; 18: 841-52.
Badawi N, Watson L, Petterson B, Blair E, Slee J, Haan E, Stanley F. What constitutes cerebral palsy? Dev Med Child Neurol 1998; 40: 520-7.
StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013.
Fleiss J. Statistical Methods for Rates and Proportions. New York, NY: John Wiley; 1981.
Nylén E, Grooten WJ. The stability of the gross motor function classification system in children with cerebral palsy living in Stockholm and factors associated with change. Phys Occup Ther Pediatr 2020; 41: 138-49.

Auteurs

Menal Huroy (M)

Faculty of Medicine, McGill University, QC, Canada.

Tarannum Behlim (T)

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, QC, Canada.

John Andersen (J)

Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.

David Buckley (D)

Janeway Children's Hospital, St. John's, NL, Canada.

Darcy Fehlings (D)

Department of Paediatrics, University of Toronto, Bloorview Research Institute, Toronto, ON, Canada.

Adam Kirton (A)

Departments of Pediatrics and Clinical Neurosciences, Cumming School of Medicine, University of Calgary, AB, Canada.

Nicole Pigeon (N)

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.

Ram A Mishaal (RA)

Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.

Ellen Wood (E)

IWK Health Centre, Halifax, NS, Canada.

Michael Shevell (M)

Department of Pediatrics and Neurology and Neurosurgery, McGill University, QC, Canada.

Maryam Oskoui (M)

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, QC, Canada.
Department of Pediatrics and Neurology and Neurosurgery, McGill University, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH